3 ms·
For nefazodone, we had other antidepressants (so why take the risk?), and it was only taken off the market when it went generic (lol). For BP medication, hopef
by Scoundreller 7y ago
For nefazodone, we had other antidepressants (so why take the risk?), and it was only taken off the market when it went generic (lol).
For BP medication, hopefully at least 1 in 100 recipients are benefitting from it. Probably more like 1 in 10. Overall, don't stop taking it. Reducing the cancer risk is possible and feasible in this case without changing therapy.
We'll probably see further testing of APIs and validation of synthetic route changes in the future because of it.